Estrogenic activity of diarylheptanoids from Curcuma comosa Roxb. requires metabolic activation

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 3, 2009, Pages 840-845

  Winuthayanon, Wipawee ^a   Suksen, Kanoknetr ^a   Boonchird, Chuenchit ^a   Chuncharunee, Aporn ^b   Ponglikitmongkol, Mathurose ^a   Suksamrarn, Apichart ^c   Piyachaturawat, Pawinee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c RAMKHAMHAENG UNIVERSITY   (Thailand)

Author keywords

Curcuma comosa; Diarylheptanoid; Estrogenic activity; Phytoestrogen; Uterotrophic; Wan chak motluk

Indexed keywords

CURCUMA COMOSA; CURCUMA LONGA; RATTUS;

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HEPTANE DERIVATIVE; PHYTOESTROGEN; PLANT EXTRACT;

ANIMAL; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; CURCUMA LONGA; DRUG EFFECT; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ORGAN SIZE; OVARIECTOMY; RAT; SACCHAROMYCES CEREVISIAE; UTERUS; WISTAR RAT;

ANIMALS; CURCUMA; DIARYLHEPTANOIDS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; ORGAN SIZE; OVARIECTOMY; PHYTOESTROGENS; PLANT EXTRACTS; RATS; RATS, WISTAR; SACCHAROMYCES CEREVISIAE; UTERUS;

EID: 61449169095     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf802702c     Document Type: Article

References (32)

1. Gruber, C. J.; Tschugguel, W.; Schneeberger, C.; Huber, J. C. Production and actions of estrogens. N. Engl. J. Med. 2002, 346, 340-352.
2. Couse, J. F.; Lindzey, J.; Grandien, K.; Gustafsson, J. A.; Korach, K. S. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERα) and estrogen receptor-beta (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology 1997, 138, 4613-4621.
3. Nilsson, S.; Makela, S.; Treuter, E.; Tujague, M.; Thomsen, J.; Andersson, G.; Enmark, E.; Pettersson, K.; Warner, M.; Gustafsson, J. A. Mechanisms of estrogen action. Physiol. Rev. 2001, 81, 1535-1565.
4. Hewitt, S. C.; Korach, K. S. Estrogen receptors: structure, mechanisms and function. Rev. Endocr. Metab. Disord. 2002, 3, 193-200.
5. Prior, J. C. Perimenopause: the complex endocrinology of the menopausal transition. Endocr. Rev. 1998, 19, 397-428.
6. Mangione, C. M.; Briceland-Betts, D.; Ellenberg, S. S.; Emerson, S. S.; Espino, D. V.; Fife, R. S.; Folkman, S.; Handerson, C. E.; Macdaniel, S. H.; Verbrugge, L. M.; Washington, D. L.; Woolf, P. National Institutes of Health State-of-the-Science Conference Statement: Management of Menopause-Related Symptoms. Ann. Intern. Med. 2005, 142, 1003-1013.
7. Beral, V.; Banks, E.; Reeves, G.; Appleby, P. Use of HRT and the subsequent risk of cancer. J. Epidemiol. Biostat. 1999, 4, 191-210.
8. Genazzani, A. R.; Gadducci, A.; Gambacciani, M. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. Maturitas 2001, 40, 117-130.
9. Yeh, I. T. Postmenopausal hormone replacement therapy: endometrial and breast effects. Adv. Anat. Pathol. 2007, 14, 17-24.
10. Penalvo, J. L.; Heinonen, S. M.; Nurmi, T.; Deyama, T.; Nishibe, S.; Adlercreutz, H. Plant lignans in soy-based health supplements. J. Agric. Food Chem. 2004, 52, 4133-4138.
11. Usui, T. Pharmaceutical prospects of phytoestrogens. Endocr. J. 2006, 53, 7-20.
12. Kurzer, M. S.; Xu, X. Dietary phytoestrogens. Annu. Rev. Nutr. 1997, 17, 353-381.
13. Limer, J. L.; Speirs, V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res. 2004, 6, 119-127.
14. Carusi, D. Phytoestrogens as hormone replacement therapy: an evidence-based approach. Prim. Care Update Obstet. Gynecol. 2000, 7, 253-259.
15. Kurzer, M. S. Phytoestrogen supplement use by women. J. Nutr. 2003, 133, 1983S-1986S.
16. Yang, H. M.; Liao, M. F.; Zhu, S. Y.; Liao, M. N.; Rohdewald, P. A randomised, double-blind, placebo-controlled trial on the effect of pycnogenol on the climacteric syndrome in perimenopausal women. Acta Obstet. Gynecol. Scand. 2007, 86, 978-985.
17. Huntley, A. L.; Ernst, E. Soy for the treatment of perimenopausal symptoms - a systematic review. Maturitas 2004, 47, 1-9.
18. Dai, Q.; Shu, X. O.; Jin, F.; Potter, J. D.; Kushi, L. H.; Teas, J.; Gao, Y. T.; Zheng, W. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br. J. Cancer 2001, 85, 372-378.
19. Suksamrarn, A.; Ponglikitmongkol, M.; Wongkrajang, K.; Chindaduang, A.; Kittidanairak, S.; Jankam, A.; Yingyongnarongkul, B. E.; Kittipanumat, N.; Chokchaisiri, R.; Khetkam, P.; Piyachaturawat, P. Diarylheptanoids, new phytoestrogens from the rhizomes of Curcuma comosa: isolation, chemical modification and estrogenic activity evaluation. Bioorg. Med. Chem. 2008, 16, 6891-6902.
20. Takatori, S.; Kitagawa, Y.; Oda, H.; Miwa, G.; Nishikawa, J.-I.; Nishihara, T.; Nakazawa, H.; Hori, S. Estrogenicity of metabolites of benzophenone derivatives examined by a yeast two-hybrid assay. J. Health Sci. 2003, 49, 91-98.
21. Nishikawa, J.; Saito, K.; Goto, J.; Dakeyama, F.; Matsuo, M.; Nishihara, T. New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicol. Appl. Pharmacol. 1999, 154, 76-83.
22. Jordan, V. C.; Mittal, S.; Gosden, B.; Koch, R.; Lieberman, M. E. Structure-activity relationships of estrogens. Environ. Health Perspect. 1985, 61, 97-110.
23. Brzozowski, A. M.; Pike, A. C.; Dauter, Z.; Hubbard, R. E.; Bonn, T.; Engstrom, O.; Ohman, L.; Greene, G. L.; Gustafsson, J. A.; Carlquist, M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389, 753-758.
24. Kekenes-Huskey, P. M.; Muegge, I.; von Rauch, M.; Gust, R.; Knapp, E. W. A molecular docking study of estrogenically active compounds with 1,2-diarylethane and 1,2-diarylethene pharmacophores. Bioorg. Med. Chem. 2004, 12, 6527-6537.
25. Coldham, N. G.; Dave, M.; Sivapathasundaram, S.; McDonnell, D. P.; Connor, C.; Sauer, M. J. Evaluation of a recombinant yeast cell estrogen screening assay. Environ. Health Perspect. 1997, 105, 734-742.
26. Penttinen, P.; Jaehrling, J.; Damdimopoulos, A. E.; Inzunza, J.; Lemmen, J. G.; van der Saag, P.; Pettersson, K.; Gauglitz, G.; Makela, S.; Pongratz, I. Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 2007, 148, 4875-4886.
27. Peterson, T. G.; Ji, G. P.; Kirk, M.; Coward, L.; Falany, C. N.; Barnes, S. Metabolism of the isoflavones genistein and biochanin A in human breast cancer cell lines. Am. J. Clin. Nutr. 1998, 68, 1505S-1511S.
28. Ireson, C.; Orr, S.; Jones, D. J.; Verschoyle, R.; Lim, C. K.; Luo, J. L.; Howells, L.; Plummer, S.; Jukes, R.; Williams, M.; Steward, W. P.; Gescher, A. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 2001, 61, 1058-1064.
29. Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Aggarwal, B. B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4, 807-818.
30. Pan, M. H.; Huang, T. M.; Lin, J. K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 1999, 27, 486-494.
31. Wahlstrom, B.; Blennow, G. A study on the fate of curcumin in the rat. Acta Pharmacol. Toxicol. (Copenh.) 1978, 43, 86-92.
32. Ireson, C. R.; Jones, D. J.; Orr, S.; Coughtrie, M. W.; Boocock, D. J.; Williams, M. L.; Farmer, P. B.; Steward, W. P.; Gescher, A. J. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 105-111.